Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cells.
第一作者:
Susan C,Short
第一单位:
UCL Cancer Institute, University College London, London, UK. s.short@ucl.ac.uk
作者:
医学主题词
抗原, CD(Antigens, CD);抗肿瘤药, 烷基化(Antineoplastic Agents, Alkylating);细胞凋亡(Apoptosis);印迹法, 蛋白质(Blotting, Western);脑肿瘤(Brain Neoplasms);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);综合疗法(Combined Modality Therapy);DNA修复(DNA Repair);达卡巴嗪(Dacarbazine);流式细胞术(Flow Cytometry);荧光抗体技术(Fluorescent Antibody Technique);神经胶质瘤(Glioma);糖蛋白类(Glycoproteins);人类(Humans);免疫酶技术(Immunoenzyme Techniques);肽类(Peptides);RNA, 信使(RNA, Messenger);RNA, 小分子干扰(RNA, Small Interfering);Rad51重组酶(Rad51 Recombinase);辐射耐受性(Radiation Tolerance);逆转录聚合酶链反应(Reverse Transcriptase Polymerase Chain Reaction);X线(X-Rays)
DOI
10.1093/neuonc/nor010
PMID
21363882
发布时间
2025-05-29
- 浏览10
Neuro-oncology
487-99页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



